Mouillaux, Julie
Allam, Camille
Rimmelé, Thomas
Uberti, Thomas
Delwarde, Benjamin
Textoris, Julien
Monneret, Guillaume
Peronnet, Estelle http://orcid.org/0000-0002-6764-8931
Venet, Fabienne
Article History
Received: 7 August 2018
Accepted: 26 December 2018
First Online: 8 January 2019
Ethics approval and consent to participate
: Septic shock patients: this project was approved by our Institutional Review Board for ethics (“Comité de Protection des Personnes Sud-Est II”), which waived the need for informed consent, because this study was observational and performed on residual blood after completion of routine follow-up (#IRB 11236). This study is registered at the French Ministry of Research and Teaching (#DC-2008-509), at the Commission Nationale de l’Informatique et des Libertés and on clinicaltrials.gov (NCT02803346). Non-opposition to inclusion in the study was registered for each patient.Healthy volunteers: peripheral blood from healthy volunteers was provided by the “Etablissement Français du Sang” from Lyon. According to the standardized procedure for blood donation, written informed consent was obtained from healthy volunteers and personal data were anonymized at time of blood donation and before blood transfer to our research lab.
: Not applicable.
: JM, JT, and EP are employees of bioMérieux. BD, FV, GM, EP, and JT are co-inventors on three patent families covering IL-7 receptor biomarkers. This work was supported by Association Nationale de la Recherche et de la Technologie (JM, Convention Industrielle de Formation par la Recherche convention 2015/060).
: Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.